BerandaRGEN • NASDAQ
add
Repligen Corp
$142,58
Setelah Jam Perdagangan Normal:(0,00%)0,00
$142,58
Tutup: 22 Nov, 16.05.02 GMT-5 · USD · NASDAQ · Pernyataan Penyangkalan
Tutup sebelumnya
$141,76
Rentang hari
$140,59 - $145,21
Rentang tahun
$113,50 - $211,13
Kapitalisasi pasar
7,99Â M USD
Volume Rata-Rata
687,92Â rb
Rasio P/E
-
Hasil dividen
-
Bursa utama
NASDAQ
Dalam berita
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 154,87Â jt | 9,69% |
Biaya operasional | 83,65Â jt | 28,98% |
Laba bersih | -654,00Â rb | -103,86% |
Margin laba bersih | -0,42 | -103,50% |
Penghasilan per saham | 0,43 | 86,96% |
EBITDA | 12,72Â jt | 22,14% |
Tarif pajak efektif | 43,08% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 783,96Â jt | 24,29% |
Total aset | 2,83Â M | 12,59% |
Total liabilitas | 813,96Â jt | 54,87% |
Total ekuitas | 2,02 M | — |
Saham yang beredar | 56,03 jt | — |
Harga terhadap nilai buku | 3,94 | — |
Tingkat pengembalian aset | -0,41% | — |
Tingkat pengembalian modal | -0,43% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | -654,00Â rb | -103,86% |
Kas dari operasi | 49,32Â jt | 25,72% |
Kas dari investasi | -5,86Â jt | 33,19% |
Kas dari pembiayaan | -69,60Â jt | -8.846,53% |
Perubahan kas bersih | -25,18Â jt | -192,84% |
Arus kas bebas | 37,87Â jt | -23,71% |
Tentang
Repligen Corporation is an American company devoted to the development and production of materials used in the manufacture of biological drugs. The company is based in Waltham, Massachusetts, and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. In February 2014, Repligen had employed 116 people, about 50% of these based in Sweden. Wikipedia
CEO
Didirikan
1981
Kantor pusat
Situs
Karyawan
1.783
